nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Clinicians’ Attitude to Doublet Plus Anti-EGFR Versus Triplet Plus Bevacizumab as First-line Treatment in Left-Sided RAS and BRAF Wild-Type Metastatic Colorectal Cancer Patients: A Multicenter, “Real-Life”, Case-Control Study
|
Parisi, Alessandro |
|
|
20 |
4 |
p. 318-325 |
artikel |
2 |
Colonic Squamous Cell Carcinoma in a Patient With Lynch Syndrome: Case Report and Highlights on the Role of Biomarker-Led Management
|
Kussaibati, R. |
|
|
20 |
4 |
p. e226-e232 |
artikel |
3 |
Conversion Therapy With Encorafenib and Cetuximab for Chemo-Refractory BRAF V600E-Mutated Liver-Limited Colorectal Cancer Metastasis: The First Case Report
|
Calegari, Maria Alessandra |
|
|
20 |
4 |
p. 364-367 |
artikel |
4 |
Cutaneous Lymphangitic Carcinomatosis as the First Sign of Recurrent Malignancy in a Patient With a History of Rectal Adenocarcinoma
|
Lebeck Lee, Cody |
|
|
20 |
4 |
p. 368-371 |
artikel |
5 |
Editorial Board
|
|
|
|
20 |
4 |
p. A1 |
artikel |
6 |
Long Term Survival With Regorafenib: REALITY (Real Life in Italy) Trial - A GISCAD Study
|
Lai, Eleonora |
|
|
20 |
4 |
p. e253-e262 |
artikel |
7 |
Mucinous Adenocarcinoma Predicts Poor Response and Prognosis in Patients With Locally Advanced Rectal Cancer: A Pooled Analysis of Individual Participant Data From 3 Prospective Studies
|
Zhang, Jianwei |
|
|
20 |
4 |
p. e240-e248 |
artikel |
8 |
Multiple Acquired Mutations Captured by Liquid Biopsy in the EGFR Addicted Metastatic Colorectal Cancer
|
Guerrera, Luigi Pio |
|
|
20 |
4 |
p. 354-358 |
artikel |
9 |
Outcomes of Patients With Metastatic Anal Cancer According to HIV Infection: A Multicenter Study by the Latin American Gastrointestinal Oncology Group (SLAGO)
|
Mattos, Bruna R.S. |
|
|
20 |
4 |
p. 299-304 |
artikel |
10 |
Phase II Trial of Trametinib and Panitumumab in RAS/RAF Wild Type Metastatic Colorectal Cancer
|
Alshammari, Kanan |
|
|
20 |
4 |
p. 334-341 |
artikel |
11 |
Primary Adrenal Insufficiency and Acute Cardiomyopathy in a Patient With Colorectal Cancer Treated With Dual Immune Checkpoint Inhibitors
|
Kojadinovic, Arsenije |
|
|
20 |
4 |
p. e249-e252 |
artikel |
12 |
Rationale and Study Design of the PARERE Trial: Randomized phase II Study of Panitumumab Re-Treatment Followed by Regorafenib Versus the Reverse Sequence in RAS and BRAF Wild-Type Chemo-Refractory Metastatic Colorectal Cancer Patients
|
Moretto, Roberto |
|
|
20 |
4 |
p. 314-317 |
artikel |
13 |
Relationships Between Köhne Category/Baseline Tumor Load and Early Tumor Shrinkage, Depth of Response, and Outcomes in Metastatic Colorectal Cancer
|
Sartore-Bianchi, Andrea |
|
|
20 |
4 |
p. 305-313 |
artikel |
14 |
Response to Pembrolizumab in Advanced Anal Squamous Cell Carcinoma With High TMB and PD-L1 and PD-L2 Amplification
|
Tostes, Francinne T. |
|
|
20 |
4 |
p. 350-353 |
artikel |
15 |
Sex and Regorafenib Toxicity in Refractory Colorectal Cancer: Safety Analysis of the RegARd-C Trial
|
Vandeputte, Caroline |
|
|
20 |
4 |
p. 326-333 |
artikel |
16 |
Standard-Dose Trifluridine/Tipiracil as Safe Treatment Alternative in Metastatic Colorectal Cancer Patients With DPD Deficiency
|
Schouten, Jeroen F. |
|
|
20 |
4 |
p. 359-363 |
artikel |
17 |
Suboptimal Completion Rates, Adverse Events, Costs, Resource Utilization, and Cost Impact of Noncompletion in Oral Adjuvant Capecitabine–Based Chemotherapy in Patients With Early-Stage Colon Cancer
|
Wang, Xue |
|
|
20 |
4 |
p. e215-e225 |
artikel |
18 |
Survival Benefit of Repeat Local Treatment in Patients Suffering From Early Recurrence of Colorectal Cancer Liver Metastases
|
Hellingman, Tessa |
|
|
20 |
4 |
p. e263-e272 |
artikel |
19 |
Table of contents
|
|
|
|
20 |
4 |
p. A3-A6 |
artikel |
20 |
The Evolving Field of Neoadjuvant Therapy in Locally-advanced Rectal Cancer: Evidence and Prospects
|
Ominelli, Juliana |
|
|
20 |
4 |
p. 288-298 |
artikel |
21 |
The Stage Migration Should be Reconsidered in Stage IIIA Rectal Cancer: Based on Propensity Score Analysis
|
Shin, Jung Kyong |
|
|
20 |
4 |
p. e273-e278 |
artikel |
22 |
Treatment and Outcomes of Oligometastatic Colorectal Cancer Limited to Lymph Node Metastases
|
Mathai, Vinod Kalapurackal |
|
|
20 |
4 |
p. e233-e239 |
artikel |
23 |
Treatment of Squamous Cell Carcinoma of the Anus, Unresolved Areas and Future Perspectives for Research: Perspectives of Research Needs in Anal Cancer
|
Guren, Marianne Grønlie |
|
|
20 |
4 |
p. 279-287 |
artikel |
24 |
Trifluridine/Tipiracil in Metastatic Colorectal Cancer: A UK Multicenter Real-world Analysis on Efficacy, Safety, Predictive and Prognostic Factors
|
Stavraka, Chara |
|
|
20 |
4 |
p. 342-349 |
artikel |